Evidence map›Paper›PMID 42362703›Full record

ArticleScientific reports2026

Helmet detection in traffic scenarios: enhanced performance for complex environments.

Hua Hou, Tianxiang Tan, Diancheng Wang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hua HouSchool of Information and Electrical Engineering, Hebei University of Engineering, Handan, 056038, China. houhua@hebeu.edu.cn.
Tianxiang TanSchool of Information and Electrical Engineering, Hebei University of Engineering, Handan, 056038, China.
Diancheng WangSchool of Information and Electrical Engineering, Hebei University of Engineering, Handan, 056038, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the cutting-edge development of computer vision technology, the high missed detection rate caused by target occlusion and the high computational cost of model inference remain core technical bottlenecks restricting the deployment of robust object detection systems in real-world scenarios. This paper presents an improved YOLOv10n-based algorithm to address these issues. Adaptive-DySample (ADS) enhances target detection via three innovative mechanisms-dynamic alignment, challenging sample prioritization, and multi-scale fusion with range adjustment-enabling flexible, object-aware upsampling to overcome traditional limitations. C2fCIB-Fusion(C2fCIB-F), built on the original C2fCIB, systematically addresses the shortcomings of traditional modules in terms of feature extraction flexibility, multi-scale adaptability, and inference efficiency through a series of methods: integrating multi-scale and dynamic channel optimization, introducing Spatial-Channel Interaction, adopting RepVGGDW, and utilizing residual connections. Additionally, Gated Multi-Scale Fusion Convolution (GMFConv) uses a dual-branch architecture (one for global features, one for local details) with a gating mechanism for feature fusion, enhancing small object detection capability and being lightweight for resource-constrained scenarios. Experimental results show the improved model achieves 2.4% higher mAP@0.5 and 5.1% better parameter than the original. It significantly enhances helmet detection accuracy under complex scenarios, maintains real-time performance, and balances a lightweight design, suitable for edge computing and safety monitoring systems.

Indexed as

ADSC2fCIB-FGMFConvHelmet DetectionYOLOv10n

Identifiers

PMID42362703
PMCPMC13385860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.